Characteristics | Participants (% of total) | Isolates with ESBL/AmpC production alone | Isolates with ciprofloxacin-non susceptibility alone | Isolates with both ESBL/AmpC and ciprofloxacin non-susceptibility | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 |  | EAP (% within group) | Non-EAP (% within group) | p-value | CNS (% within group) | Non-CNS (% within group) | p-value | EAP + CNS (% within group) | Non EAP + CNS (% within group) | p-value |
Gender (information missing for 8) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Female | 174 (61.3) | 11 (6.3) | 163 (93.6) | .746 | 11 (6.3) | 163 (93.6) | .375 | 5 (2.9) | 169 (97.1) | 1.0 |
Male | 102 (35.9) | 4 (3.9) | 98 (96.1) | Â | 11 (10.8) | 91 (89.2) | Â | 3 (2.9) | 99 (97.1) | Â |
Age group (years; information missing for 3) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
18-29 | 53 (18.7) | 6 (2.1) | 47 (97.9) | .222 | 3 (5.7) | 50 (94.3) | .944 | 1 (1.9) | 52 (98.1) | .239 |
30-49 | 108 (38.0) | 4 (3.7) | 104 (96.3) | Â | 8 (7.4) | 100 (92.6) | Â | 1 (0.9) | 107 (99.1) | Â |
50-64 | 76 (26.8) | 4 (5.3) | 72 (94.7) | Â | 6 (7.9) | 70 (92.1) | Â | 4 (5.3) | 72 (94.7) | Â |
65-84 | 44 (15.5) | 1 (2.3) | 43 (97.7) | Â | 4 (9.1) | 40 (90.9) | Â | 2 (4.5) | 42 (95.5) | Â |
Geographic regions# visited last 3Â months | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Not travelled /travelled within Scandinavia | 194 (68.3) | 9 (4.6) | 185 (95.4) | Â | 11 (5.7) | 183 (94.3) | Â | 4 (2.1) | 190 (97.9) | Â |
Europe (outside Scandinavia) | 69 (24.3) | 2 (2.9) | 67 (97.1) | .002 | 6 (8.7) | 63 (91.3) | .040 | 2 (2.9) | 67 (97.1) | .145 |
America | 1 (0.4) | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â |
Eastern Mediterranean | 2 (0.7) | 1 (50) | 1 (50) | Â | 0 (0) | 2 (100) | Â | 0 (0) | 2 (100) | Â |
South-East Asia | 4 (1.4) | 3 (75)** | 1 (25) | Â | 1 (25) | 3 (75) | Â | 1 (25) | 3 (75) | Â |
Western Pacific | 2 (0.7) | 0 (0) | 2 (100) | Â | 1 (50) | 1 (50) | Â | 0 (0) | 2 (100) | Â |
Africa | 1 (0.4) | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â |
Multiple regions | 11 (3.9) | 0 (0) | 11 (100) | Â | 3 (27.3)* | 8 (72.7) | Â | 1 (0.9) | 10 (99.1) | Â |
Geographic regions# visited last 12Â months | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Not travelled /travelled within Scandinavia | 101 (35.6) | 5 (5.0) | 96 (95.0) | Â | 8 (7.9) | 93 (92.1) | Â | 1 (0.6) | 100 (99.4) | Â |
Europe (outside Scandinavia) | 133 (46.8) | 6 (4.5) | 127 (95.5) | .089 | 6 (4.5) | 127 (95.5) | .051 | 3 (2.3) | 130 (97.7) | .045 |
America | 1 (0.4) | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â |
Eastern Mediterranean | 2 (0.7) | 1 (50) | 1 (50) | Â | 0 (0) | 2 (100) | Â | 0 (0) | 2 (100) | Â |
South-East Asia | 2 (0.7) | 1 (50) | 1 (50) | Â | 0 (0) | 2 (100) | Â | 1 (50)* | 1 (50) | Â |
Western Pacific | 1 (0.4) | 0 (0) | 1 (100) | Â | 1 (100) | 0 (0) | Â | 0 (0) | 1 (100) | Â |
Africa | 1 (0.4) | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â | 0 (0) | 1 (100) | Â |
Multiple regions | 43(15.1) | 2 (4.7) | 41(95.3) | Â | 7 (16.3) | 36 (83.7) | Â | 3 (7.0) | 40 (93.0) | Â |
Total | 284 (100) | 15 (5.3) | 269 (94.7) | Â | 22 (7.7) | 262 (92.3) | Â | 8 (2.8) | 276 (97.2) | Â |